• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • PIPELINE
  • News and Updates
  • Presentation
  • Covid-19 experiments
  • In the Media
12 Mar
Annnouncements

VAXIL ANNOUNCES 2021 RESEARCH AND DEVELOPMENT STRATEGY AND PROGRESS

… Read the rest
Posted on March 12, 2021 by David Goren
17 Feb
Annnouncements

VAXIL PROVIDES STRATEGY UPDATE FROM CONCLUSION OF COVID-19 CHALLENGE STUDY

… Read the rest
Posted on February 17, 2021 by David Goren
01 Feb
Annnouncements

VAXIL APPOINTS A SPECIAL ADVISOR TO THE BOARD OF DIRECTORS

… Read the rest
Posted on February 1, 2021 by David Goren
27 Jan
Annnouncements

VAXIL PROVIDES UPDATE ON USAMRIID, ORAL EXPERIMENT AND OTHER GENERAL BUSINESS MATTERS

… Read the rest
Posted on January 27, 2021 by David Goren
02 Jan
Annnouncements

VAXIL’S ANNUAL AND SPECIAL SHAREHOLDERS MEETING AND UPDATE ON EXERCISE OF WARRANTS

… Read the rest
Posted on January 2, 2021 by David Goren
Older posts

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2021 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • PIPELINE
  • News and Updates
  • Presentation
  • Covid-19 experiments
  • In the Media
  • Vaxil Locations
  • Contact Us
  • Subscribe